Dead Words Eulogy This is a bonus lecture provided to RheumNow Live 2024 registrants, and being shared with our RheumNow audience. Today is the last day to register to attend virtually (or in person); go to https://t.co/fc9DGbVDJ5 for more information. https://t.co/d4IbIbAIX8 https://t.co/egNtTNincb

Celebrities/famous folk who've had hip replacement: Steve Carrell Arnold Schwarzenegger, Michael Douglas, Billy Joel, Jane Fonda, Ray Charles, Eddie Van Halen, Bob Hope, Steve Perry, Lionel Richie, Alec Baldwin & soon Paulina Porizkova https://t.co/z3v39gxAZa https://t.co/uqNJuPLUHL

No evidence of harm starting urate lowering Tx (ULT) during #gout attack. Metanalysis 6 RCTs (445 pts) w/ gout attacks given ULT vs PBO or delayed ULT. No differences in pain, time to resolve gout flare or risk of recurrent gout flare in 30d (RR 1.06) https://t.co/Spxoe3CI1q https://t.co/ECya8rvf1S

Microbiome study of 16 SLE pts (44 fecal samples) shows that blooms of Ruminococcus gnavus pathobiont was assoc w/ lupus flares and may be the drivers of clinical of relapsing lupus disease https://t.co/DIir59dkdM https://t.co/0p7Pat4gXS

Biden administration will re-negotiate top 10 Medicare costly drugs - this includes two of interest to rheumatologists 1. Stelara (ustekinumab) - avg Part D Rx cost = $119,951 2. Enbrel (etanercept) - avg Pt D Rx cost = $58,148 https://t.co/HuXmFodZfd https://t.co/BuGl34Zpv5 https://t.co/uniQoEywDB

FDA Safety Warning: denosumab now has a Boxed Warning for risk of severe hypocalcemia in CKD pts taking Prolia (usually seen 2-10 wks post injx). Pts may or may not be symptomatic. CKD pts should have Ca and Creatinine monitored. https://t.co/UMYxjWz9n4 https://t.co/AG5wzBrY1Y

Rheumatologists and the Early Diagnosis of Spondyloarthritis SPACE study of adults referred to rheumatology with less than 2 years of chronic back pain (CBP), shows that only one-third can be reliably diagnosed with axial spondyloarthritis (axSpA). https://t.co/nUappTl0wG. https://t.co/oouir55CO6

Prevalence of Cardiovascular Disease in Rheumatoid Arthritis A prospective study of the BioSTAR registry estimates the prevalence of cardiovascular disease in rheumatoid arthritis (RA) to be 4.6%. https://t.co/NRn0DrYoBX https://t.co/qOoTmBNB1p

Oh, snap! But this is true, a single course rituximab at baseline and none at 6 months (or anything else) as a comparator is just wild in a 12 month trial @EBRheum @RheumNow #RNL2024 https://t.co/wuIkuLzIpg

A picture paints a thousand words. One of the reasons why statistical significance is not the be all and end all. I would say severe DAH is the most likely scenario I would use PLEX, more so than severe renal disease. @EBRheum @RheumNow #RNL2024 https://t.co/GHg6t4OHxf

Rituximab is superior to cyclophosphamide in relapsing AAV. Provided you are relapsing after having cyclophosphamide as your first agent of course... @EBRheum @RheumNow #RNL2024 https://t.co/JfbcKH2zCG